AI skills decay over time, but cognitive, accuracy-dependent skills (like judging a regulator-facing output) erode three times faster than procedural skills (running a workflow). Companies often measure the slower-decaying half, missing the critical loss of judgment capability, which carries the most regulatory consequence.
Training that raises employee enthusiasm for AI tools without embedding deep, contextual judgment is counterproductive. It increases AI use in high-stakes workflows faster than the organization's ability to control for errors, creating a risk funded by the training budget itself and leaving the company more exposed than before.
An employee's AI journey often includes an 'over-reliance' stage, where enthusiasm leads them to unknowingly outsource their thinking. This stage feels like peak performance and confidence to the user, making it invisible on standard satisfaction surveys and creating a significant hidden risk for the organization.
Company-wide learning platforms are insufficient for pharma because they teach general AI principles. They fail to address the specific, high-stakes judgments required in functional workflows, like deciding if a generated regulatory summary is defensible or a promotional claim is substantiated, leaving employees with unanswered questions for their roles.
The EU AI Act's Article 4 creates a literacy duty requiring training to account for the 'context in which it is used.' This elevates the standard from generic awareness to role-specific capability. A completion record from a generic program is insufficient documentation for this regulatory requirement, which applies even to non-EU firms whose AI output is used in the EU.
A significant, overlooked risk is that existing, fully approved software is constantly updated with new AI features. These capabilities are added post-procurement and bypass initial compliance and regulatory checks, introducing unvetted AI into sensitive, regulated workflows without anyone noticing, creating a major governance blind spot.
When employees use unapproved AI tools, it shouldn't be seen merely as a compliance violation. It is often a strong signal that the officially sanctioned tools and training are inadequate for their workflow needs. This behavior highlights a critical gap in the company's enablement strategy that needs to be addressed proactively.